FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367304816> ?p ?o ?g. }

• W4367304816 abstract "<h3>Objective:</h3> To assess in an outpatient setting the application of volumetrics with brain MRI among young people with multiple sclerosis (MS). <h3>Background:</h3> Research on brain atrophy in MS has illuminated how inflammation and neurodegenerative processes lead to cognitive and neurologic declines. However, brain volume assessment is rarely used in routine practice. Here, we examined predominantly pediatric onset MS and some younger adult-onset MS patients who underwent routine brain MRI including volumetrics. Our goal was to assess the impact of brain volume change on clinical outcomes including SDMT in this relatively young and stable MS subset. <h3>Design/Methods:</h3> 77 patients with pediatric or adult onset RRMS or CIS, 31 years of age or younger, were evaluated with at least two MRI studies. Volume data was computed on MRI images with icobrain ms software, compared to age- and sex-related norms and adjusted for differences across the various Siemens 3T scanners. Changes in volumes of whole brain (WB), white matter (WM), grey matter (GM), lateral ventricles (LV), and thalamus were calculated as an average annualized percent brain volume change per year. <h3>Results:</h3> The mean patient age was 21.6 years (range 12–31); 70% were female. The annual mean decrease of WB volume: −0.473%, WM: −0.390%, GM: −0.517%, thalamus: −0.552%, and annual LV volume increase: 1.78%. A total of 32.5% of patients had an annual decrease in GM volume >0.8% (the 90% threshold for measurement error). 29.9% of patients had LV volumes increase >3.5%. Whole brain volume loss and lateral ventricle increase was significantly correlated, r=−0.34 (p=0.002). Clinical and demographic features between those whose brain volume declined and those whose brain volumes remained stable will be presented. <h3>Conclusions:</h3> Quantitative MRI is a useful technique which has only begun to be incorporated into clinical practice. A proportion of young otherwise stable patients with RRMS show brain volume loss under computer-assisted analyses. <b>Disclosure:</b> Dr. O’Neill has nothing to disclose. Dr. Couvreur has received personal compensation in the range of $10,000-$49,999 for serving as a Intern Clinical application specialist at icometrix with The Prince Albert Fund. Dr. Hu has nothing to disclose. Mr. Zhang has nothing to disclose. Ms. Pehel has nothing to disclose. Ms. Sosa has nothing to disclose. Ms. Fade has nothing to disclose. Elayne Feld has nothing to disclose. Dr. Chen has received personal compensation for serving as an employee of icometrix. Dr. De Barros has received personal compensation for serving as an employee of Icometrix. Thibo Billiet has received personal compensation for serving as an employee of icometrix. Annemie Ribbens, 9599 has received personal compensation for serving as an employee of icometrix. Annemie Ribbens, 9599 has stock in icometrix. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lerhman. Dr. Krupp has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for medscape. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLive. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Krupp has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Cleveland Clinic. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for MCIC. The institution of Dr. Krupp has received research support from Biogen. The institution of Dr. Krupp has received research support from National Multiple Sclerosis Society. Dr. Krupp has received intellectual property interests from a discovery or technology relating to health care." @default.
• W4367304816 created "2023-04-29" @default.
• W4367304816 creator A5001679084 @default.
• W4367304816 creator A5016433401 @default.
• W4367304816 creator A5017405490 @default.
• W4367304816 creator A5019194814 @default.
• W4367304816 creator A5055296317 @default.
• W4367304816 creator A5056468042 @default.
• W4367304816 creator A5056886091 @default.
• W4367304816 creator A5071969833 @default.
• W4367304816 creator A5079965425 @default.
• W4367304816 creator A5086664284 @default.
• W4367304816 creator A5087219475 @default.
• W4367304816 creator A5088436897 @default.
• W4367304816 creator A5089762525 @default.
• W4367304816 date "2023-04-25" @default.
• W4367304816 modified "2023-09-25" @default.
• W4367304816 title "Longitudinal Brain Volume Findings in an Outpatient Practice of Young People with MS (P11-3.001)" @default.
• W4367304816 doi "https://doi.org/10.1212/wnl.0000000000202867" @default.
• W4367304816 hasPublicationYear "2023" @default.
• W4367304816 type Work @default.
• W4367304816 citedByCount "0" @default.
• W4367304816 crossrefType "proceedings-article" @default.
• W4367304816 hasAuthorship W4367304816A5001679084 @default.
• W4367304816 hasAuthorship W4367304816A5016433401 @default.
• W4367304816 hasAuthorship W4367304816A5017405490 @default.
• W4367304816 hasAuthorship W4367304816A5019194814 @default.
• W4367304816 hasAuthorship W4367304816A5055296317 @default.
• W4367304816 hasAuthorship W4367304816A5056468042 @default.
• W4367304816 hasAuthorship W4367304816A5056886091 @default.
• W4367304816 hasAuthorship W4367304816A5071969833 @default.
• W4367304816 hasAuthorship W4367304816A5079965425 @default.
• W4367304816 hasAuthorship W4367304816A5086664284 @default.
• W4367304816 hasAuthorship W4367304816A5087219475 @default.
• W4367304816 hasAuthorship W4367304816A5088436897 @default.
• W4367304816 hasAuthorship W4367304816A5089762525 @default.
• W4367304816 hasConcept C118552586 @default.
• W4367304816 hasConcept C126322002 @default.
• W4367304816 hasConcept C126838900 @default.
• W4367304816 hasConcept C143409427 @default.
• W4367304816 hasConcept C164705383 @default.
• W4367304816 hasConcept C187212893 @default.
• W4367304816 hasConcept C2778013878 @default.
• W4367304816 hasConcept C2779246727 @default.
• W4367304816 hasConcept C2780640218 @default.
• W4367304816 hasConcept C2781172350 @default.
• W4367304816 hasConcept C2781192897 @default.
• W4367304816 hasConcept C2989005 @default.
• W4367304816 hasConcept C548259974 @default.
• W4367304816 hasConcept C58693492 @default.
• W4367304816 hasConcept C65835030 @default.
• W4367304816 hasConcept C71924100 @default.
• W4367304816 hasConceptScore W4367304816C118552586 @default.
• W4367304816 hasConceptScore W4367304816C126322002 @default.
• W4367304816 hasConceptScore W4367304816C126838900 @default.
• W4367304816 hasConceptScore W4367304816C143409427 @default.
• W4367304816 hasConceptScore W4367304816C164705383 @default.
• W4367304816 hasConceptScore W4367304816C187212893 @default.
• W4367304816 hasConceptScore W4367304816C2778013878 @default.
• W4367304816 hasConceptScore W4367304816C2779246727 @default.
• W4367304816 hasConceptScore W4367304816C2780640218 @default.
• W4367304816 hasConceptScore W4367304816C2781172350 @default.
• W4367304816 hasConceptScore W4367304816C2781192897 @default.
• W4367304816 hasConceptScore W4367304816C2989005 @default.
• W4367304816 hasConceptScore W4367304816C548259974 @default.
• W4367304816 hasConceptScore W4367304816C58693492 @default.
• W4367304816 hasConceptScore W4367304816C65835030 @default.
• W4367304816 hasConceptScore W4367304816C71924100 @default.
• W4367304816 hasLocation W43673048161 @default.
• W4367304816 hasOpenAccess W4367304816 @default.
• W4367304816 hasPrimaryLocation W43673048161 @default.
• W4367304816 hasRelatedWork W1982011344 @default.
• W4367304816 hasRelatedWork W2005289459 @default.
• W4367304816 hasRelatedWork W2116135717 @default.
• W4367304816 hasRelatedWork W2117072734 @default.
• W4367304816 hasRelatedWork W2122154619 @default.
• W4367304816 hasRelatedWork W2124604229 @default.
• W4367304816 hasRelatedWork W220777649 @default.
• W4367304816 hasRelatedWork W3020438786 @default.
• W4367304816 hasRelatedWork W4282837588 @default.
• W4367304816 hasRelatedWork W1995670651 @default.
• W4367304816 isParatext "false" @default.
• W4367304816 isRetracted "false" @default.
• W4367304816 workType "article" @default.